Papers/PMID:40753604
Influence of intravenous iron therapy on mortality and cardiovascular events of patients on hemodialysis: A meta-analysis.
Biomolecules & biomedicine2025The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
iron(2+) — no detected effect on all-cause mortality
ModerateEvidence strength: moderate. Human evidence with one recorded weakness, or capped at moderate by its design or by unread numbers.FindingNull resultreplicated ×1“Compared to placebo/usual care, IV iron did not significantly affect all-cause mortality (OR: 1.36; 95% CI: 0.60-3.09) or MACEs (OR: 0.81; 95% CI: 0.43-1.55), with a moderate level of evidence.”
Quoted verbatim from Influence of intravenous iron therapy on mortality and cardiovascular events of patients on hemodialysis: A meta-analysis.. - Study
- meta-analysis
- Population
- Adults on maintenance hemodialysis; pooled randomised trials of intravenous iron against placebo or usual care
Effect 1.36 odds ratio, 95% CI 0.6 to 3.09
Influence of intravenous iron therapy on mortality and cardiovascular events of patients on hemodialysis: A meta-analysis.2025PMID:40753604Permalink